Decay-accelerating factor modulates induction of T cell immunity - Wikidata - awgldk - TriplyDB

Decay-accelerating factor modulates induction of T cell immunity

Decay-accelerating factor modulates induction of T cell immunity

http://www.wikidata.org/entity/Q36403001

about

Complement regulation of T-cell alloimmunity Complement regulation of T cell immunity Effects of complement activation on allograft injury Interaction of Decay-Accelerating Factor with Echovirus 7 A novel role for CD55 in granulocyte homeostasis and anti-bacterial host defense Complement System Part II: Role in Immunity Discovery, linkage disequilibrium and association analyses of polymorphisms of the immune complement inhibitor, decay-accelerating factor gene (DAF/CD55) in type 1 diabetes Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium.Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection.Molecules Great and Small: The Complement System.Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells.A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium Current status of xenotransplantation and prospects for clinical application The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury Role and mechanism of action of complement in regulating T cell immunity.Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin.Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.The complement system Efficient osteoclast differentiation requires local complement activation.Complement anaphylatoxins as immune regulators in cancer.Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants.The role of hyaluronan degradation products as innate alloimmune agonists.Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.Toxicology of autoimmune diseases.Expression of complement components, receptors and regulators by human dendritic cells.The role of the anaphylatoxins in health and disease.Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.Mesenchymal stem cells inhibit complement activation by secreting factor H.Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cells.Complement regulation of T-cell alloimmunity.Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis.Effect of complement and its regulation on myasthenia gravis pathogenesis.Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity.Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55 Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis Antigen-presenting cell-derived complement modulates graft-versus-host disease

P2860

Q26823956-FB241BE2-E8D3-4B84-9DD0-26DC026EFC06 Q26827470-C61D99C4-6D17-491F-BEBE-A6C8178CC7C9 Q26995453-5EAE7724-E4DD-439A-93A9-503E86295A69 Q27664791-3E8CE45F-C240-4269-AB39-F730E00CFAD1 Q28250093-18F5BF87-8B86-4E16-BBC1-2A3C51032C71 Q28263460-6B076876-9370-46F8-939B-ED0A1B52D3DB Q33240464-65528D67-A93F-46F4-B73D-0D1099C26761 Q33340467-CD69B6FB-1231-4AB9-A5C6-9A2CDF08A423 Q33410671-3C5E4EFC-AD23-4501-BD96-4890CB3B8A37 Q33419651-80CED904-8B95-4F06-9E78-A4FEC75D6B4D Q33570304-7EC7CA50-821C-4D67-B0EF-E527150C6426 Q33711147-531C1B55-B969-433E-AA3F-19F7EB208577 Q33802700-1F8955E7-193B-4692-80CF-BAEE71670341 Q33835678-BC6C6712-CBB7-46A7-A894-AEB161D994A8 Q33990334-CFC82749-EFD5-488A-8C88-8230F60CB4AD Q34072846-86B0E666-6717-4D61-80C4-E396FD8CB86D Q34082851-80CE9867-F8C4-48D1-8E56-0E35619CEA5F Q34086998-90D3A1D4-7EE9-4A95-8560-B6FC45558E32 Q34137841-B154DA8F-BF1A-4F72-88C6-3502419469CC Q34374041-5264700F-E0C6-455E-9877-24192ADDCE3F Q34414162-613A25A3-7CFD-45BC-933E-1CA9CA7F8460 Q34439778-38B9194E-E10B-40DE-B456-98EF7999874C Q34574846-8E49B035-AC45-4DDE-88A0-01961231C337 Q34760201-251F1173-58E0-48BF-80FC-199D4976644A Q34788943-0FD50C8D-6940-449F-AAC9-54AB6EDF74C2 Q34885229-A62366B7-EE60-4AE0-9CF1-0342C1F6183E Q34983578-D0630917-1F7B-48B9-A3DE-479F1342AFC2 Q35083760-561A2C5D-5327-4BD4-A0AC-1D290BCC9A72 Q35106559-7FB7126D-B79B-4379-A163-143B8D576FB8 Q35140939-FF203AEE-4D43-4530-AAD6-17223C0962BC Q35151737-AFF78F34-FC9B-42A1-BC0C-239C2C009F1D Q35167918-CC50420B-A2FE-49FA-8491-DE5C71D9D8AC Q35208137-E25C56B7-D44A-4211-8315-23B8D3B7FFF8 Q35221722-EAFB526B-DF92-42C6-8595-03B81D4AD8BC Q35578822-BC3DC573-0FD6-4A24-BCBA-1CC6B96B7AE2 Q35691607-74A99A5E-7D31-41A7-9F5C-4C1437A41EEA Q35884221-4237E27A-4014-4756-91AC-8B14EE5ABD51 Q35914730-80876122-798B-4587-A568-16E847AB0700 Q36001119-25729188-B7A5-42BF-93D7-77785EFE2997 Q36005386-0614BA38-4694-4864-97B6-211D18122801

P2860

Decay-accelerating factor modulates induction of T cell immunity

http://www.wikidata.org/entity/Q36403001

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Decay-accelerating factor modulates induction of T cell immunity

@ast

Decay-accelerating factor modulates induction of T cell immunity

@en

type

label

Decay-accelerating factor modulates induction of T cell immunity

@ast

Decay-accelerating factor modulates induction of T cell immunity

@en

prefLabel

Decay-accelerating factor modulates induction of T cell immunity

@ast

Decay-accelerating factor modulates induction of T cell immunity

@en

P1433

Q36403001-E214CC20-A3A3-463B-81D3-254A592BCB46

P1476

Q36403001-91566529-DE73-4A79-B6E6-116180E47069

P2093

Q36403001-067105AA-D379-4F37-990D-730000BB416D

Q36403001-0F7C3C8C-CE81-4450-91BB-86C990D3EB78

Q36403001-32586B09-16D4-4288-AAD0-ECF7E5982682

Q36403001-39D154B2-DDBB-4A41-B922-268934A9D185

Q36403001-7069DB47-E476-4900-A0A5-7E39038997DD

Q36403001-86536955-DEB8-4107-B699-DA1247647119

Q36403001-D199B9DC-FB76-4ECD-B391-F22156C08D46

Q36403001-FEF278A0-43BB-49D7-A860-963A9059E205

P2860

Q36403001-2FF50306-1E88-4AA1-BC73-BA914F1003E1

Q36403001-43559DDE-192F-45CE-B053-D9C26F03D63D

Q36403001-53E84C79-F317-4626-8975-F731BD9605FB

Q36403001-5544E873-0C51-4908-A9CA-273387156C28

Q36403001-66359266-8067-41C1-8F04-7F44F2ACC58D

Q36403001-7027983E-9792-48B5-9845-4BC7EC994CD9

Q36403001-7AC8654B-EF82-4D07-9413-4B751B9E7508

Q36403001-88DA28EF-7DAD-4D28-8E46-73FB517B5363

Q36403001-8DB3B98C-0213-40E8-BDCF-D66E63C491EB

Q36403001-998BF3DF-14FA-4E86-B576-458E4E1BE37D

P304

Q36403001-DE667AA0-2A5C-4826-A24D-3E4E28D46603

P31

Q36403001-715DCA40-6F16-4ABB-8ADB-A422FD8F9BD3

P356

Q36403001-9CD50A86-7E33-49D9-A0D4-2524DD5A261E

P407

Q36403001-3A00C5FD-8CCF-4EED-B19C-E765D8E39396

P433

Q36403001-414CAE9F-3592-484E-B614-4B7CFC4CED12

P478

Q36403001-8315C1A6-0675-4957-A57C-C07E4AF139B0

P577

Q36403001-18FA5364-95A7-424C-9CE3-B619B66FDA2E

P5875

Q36403001-083F2412-6437-41D5-9158-94CE65D3F406

P698

Q36403001-51EBAC55-F11A-4C63-90CC-7E8AD638B338

P932

Q36403001-A4129ECE-06F9-4175-A2F0-A3C08869265D

P356

P1433

Journal of Experimental Medicine

P1476

Decay-accelerating factor modulates induction of T cell immunity

@en

P2093

Anna Valujskikh

http://www.w3.org/2001/XMLSchema#string

Feng Lin

http://www.w3.org/2001/XMLSchema#string

Jinbo Liu

http://www.w3.org/2001/XMLSchema#string

M Edward Medof

http://www.w3.org/2001/XMLSchema#string

Nasima Muqim

http://www.w3.org/2001/XMLSchema#string

Peter N Lalli

http://www.w3.org/2001/XMLSchema#string

Peter S Heeger

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

GPI-microdomains: a role in signalling via immunoreceptors.

The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning.

Effector and memory T-cell differentiation: implications for vaccine development.

Activation changes the spectrum but not the diversity of genes expressed by T cells.

The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.

Cell-surface engineering with GPI-anchored proteins.

Noncovalent associations of T lymphocyte surface proteins.

P304

1523-1530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20041967

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7858281

http://www.w3.org/2001/XMLSchema#string

P698

15883171

http://www.w3.org/2001/XMLSchema#string

P932

2212927

http://www.w3.org/2001/XMLSchema#string